A splicing silencer that regulates smooth muscle specific alternative splicing is active in multiple cell types
AUTOR(ES)
Gromak, Natalia
FONTE
Oxford University Press
RESUMO
Alternative splicing of α-tropomyosin (α-TM) involves mutually exclusive selection of exons 2 and 3. Selection of exon 2 in smooth muscle (SM) cells is due to inhibition of exon 3, which requires both binding sites for polypyrimidine tract-binding protein as well as UGC (or CUG) repeat elements on both sides of exon 3. Point mutations or substitutions of the UGC-containing upstream regulatory element (URE) with other UGC elements disrupted the α-TM splicing pattern in transfected cells. Multimerisation of the URE caused enhanced exon skipping in SM and various non-SM cells. In the presence of multiple UREs the degree of splicing regulation was decreased due to the high levels of exon skipping in non-SM cell lines. These results suggest that the URE is not an intrinsically SM- specific element, but that its functional strength is fine tuned to exploit differences in the activities of regulatory factors between SM and other cell types. Co-transfection of tropomyosin reporters with members of the CUG-binding protein family, which are candidate URE-binding proteins, indicated that these factors do not mediate repression of tropomyosin exon 3.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=134246Documentos Relacionados
- Tissue-specific and developmentally regulated alternative splicing of a visceral isoform of smooth muscle myosin heavy chain.
- A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing.
- Smooth muscle alternative splicing induced in fibroblasts by heterologous expression of a regulatory gene.
- Properties of a novel K+ current that is active at resting potential in rabbit pulmonary artery smooth muscle cells.
- TIA-1 is a translational silencer that selectively regulates the expression of TNF-α